Treatment Outcomes of Patients Switching From an Injectable Drug to Bedaquiline During Short Standardized Treatment for Multidrug-resistant Tuberculosis in Mozambique

被引:7
|
作者
Bastard, Mathieu [1 ]
Molfino, Lucas [2 ]
Mutaquiha, Claudia [3 ]
Galindo, Miriam Arago [2 ]
Zindoga, Pereira [3 ]
Vaz, Deise [2 ]
Mahinca, Ivan [3 ]
DuCros, Philipp [4 ]
Rusch, Barbara [5 ]
Telnov, Alex [5 ]
机构
[1] Epictr, 8 Rue St Sabin, F-75011 Paris, France
[2] Med Sans Frontieres, Maputo, Mozambique
[3] Minis Hlth, Maputo, Mozambique
[4] Burnet Inst, Melbourne, Australia
[5] Med Sans Frontieres, Geneva, Switzerland
关键词
multidrug-resistant tuberculosis; short regimen; bedaquiline; treatment outcomes; injectable drugs;
D O I
10.1093/cid/ciz196
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Bedaquiline was recommended by the World Health Organization as the preferred option in treatment of multidrug-resistant tuberculosis (MDR-TB) with long regimens. However, no recommendation was given for the short MDR-TB regimen. Data from our small cohort of patients who switched from injectable drug to bedaquiline suggest that a bedaquiline-based short regimen is effective and safe.
引用
收藏
页码:1809 / 1811
页数:3
相关论文
共 50 条
  • [21] Acquisition of clofazimine resistance following bedaquiline treatment for multidrug-resistant tuberculosis
    Liu, Yuhong
    Gao, Jingtao
    Du, Jian
    Shu, Wei
    Wang, Lu
    Wang, Yufeng
    Xue, Zhongtan
    Li, Liang
    Xu, Shaofa
    Pang, Yu
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 102 : 392 - 396
  • [22] Plasma Drug Activity in Patients on Treatment for Multidrug-Resistant Tuberculosis
    Mpagama, Stellah G.
    Ndusilo, Norah
    Stroup, Suzanne
    Kumburu, Happiness
    Peloquin, Charles A.
    Gratz, Jean
    Houpt, Eric R.
    Kibiki, Gibson S.
    Heysell, Scott K.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (02) : 782 - 788
  • [23] Changes in treatment outcomes of multidrug-resistant tuberculosis
    Kwak, N.
    Kim, H-R
    Yoo, C-G
    Kim, Y. W.
    Han, S. K.
    Yim, J-J
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2015, 19 (05) : 525 - 530
  • [24] Development of Extensively Drug-resistant Tuberculosis during Multidrug-resistant Tuberculosis Treatment
    Shin, Sonya S.
    Keshavjee, Salmaan
    Gelmanova, Irina Y.
    Atwood, Sidney
    Franke, Molly F.
    Mishustin, Sergey P.
    Strelis, Aivar K.
    Andreev, Yevgeny G.
    Pasechnikov, Alexander D.
    Barnashov, Alexander
    Tonkel, Tamara P.
    Cohen, Ted
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 182 (03) : 426 - 432
  • [25] Global programmatic use of bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis
    Cox, V
    Brigden, G.
    Crespo, R. H.
    Lessem, E.
    Lynch, S.
    Rich, M. L.
    Waning, B.
    Furin, J.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2018, 22 (04) : 407 - +
  • [26] Treatment outcomes of multidrug-resistant tuberculosis in Switzerland
    Helbling, Peter
    Altpeter, Ekkehardt
    Egger, Jean-Marie
    Zellweger, Jean-Pierre
    SWISS MEDICAL WEEKLY, 2014, 144
  • [27] Improved Treatment Outcomes With Bedaquiline When Substituted for Second-line Injectable Agents in Multidrug-resistant Tuberculosis: A Retrospective Cohort Study
    Zhao, Ying
    Fox, Tamaryn
    Manning, Kathryn
    Stewart, Annemie
    Tiffin, Nicki
    Khomo, Ntokozo
    Leslie, Joshua
    Boulle, Andrew
    Mudaly, Vanessa
    Kock, Yulene
    Meintjes, Graeme
    Wasserman, Sean
    CLINICAL INFECTIOUS DISEASES, 2019, 68 (09) : 1522 - 1529
  • [28] Extensive Drug Resistance Acquired During Treatment of Multidrug-Resistant Tuberculosis
    Cegielski, J. Peter
    Dalton, Tracy
    Yagui, Martin
    Wattanaamornkiet, Wanpen
    Volchenkov, Grigory V.
    Via, Laura E.
    Van der Walt, Martie
    Tupasi, Thelma
    Smith, Sarah E.
    Odendaal, Ronel
    Leimane, Vaira
    Kvasnovsky, Charlotte
    Kuznetsova, Tatiana
    Kurbatova, Ekaterina
    Kummik, Tiina
    Kuksa, Liga
    Kliiman, Kai
    Kiryanova, Elena V.
    Kim, HeeJin
    Kim, Chang-ki
    Kazennyy, Boris Y.
    Jou, Ruwen
    Huang, Wei-Lun
    Ershova, Julia
    Erokhin, Vladislav V.
    Diem, Lois
    Contreras, Carmen
    Cho, Sang Nae
    Chernousova, Larisa N.
    Chen, Michael P.
    Campos Caoili, Janice
    Bayona, Jaime
    Akksilp, Somsak
    CLINICAL INFECTIOUS DISEASES, 2014, 59 (08) : 1049 - 1063
  • [29] TREATMENT OF MULTIDRUG-RESISTANT AND EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS IN ADOLESCENT PATIENTS
    Rodrigues, Magda
    Brito, Maria
    Villar, Miguel
    Correia, Paula
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2014, 33 (06) : 657 - 659
  • [30] Bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis: a multicentre cohort study in Korea
    Kim, Cheon Tae
    Kim, Tae-Ok
    Shin, Hong-Joon
    Ko, Young Chun
    Choe, Yeong Hun
    Kim, Hak-Ryul
    Kwon, Yong-Soo
    EUROPEAN RESPIRATORY JOURNAL, 2018, 51 (03)